An RNA analysis of 414 GC samples in the pan-cancer database of TCGA revealed that approximately 70% of MSI-H/dMMR GCs exhibited TMIT type I, characterized by high PD-L1 and CD8A expression [95], driving adaptive immune resistance. This evidence concerns the gene CD274 and cancer.